antipyrine has been researched along with Carcinoma, Anaplastic in 5 studies
Antipyrine: An analgesic and antipyretic that has been given by mouth and as ear drops. Antipyrine is often used in testing the effects of other drugs or diseases on drug-metabolizing enzymes in the liver. (From Martindale, The Extra Pharmacopoeia, 30th ed, p29)
antipyrine : A pyrazolone derivative that is 1,2-dihydropyrazol-3-one substituted with methyl groups at N-1 and C-5 and with a phenyl group at N-2.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study was designed to evaluate the protective effect of edaravone, a free radical scavenger, on radiation-induced brain necrosis in patients with nasopharyngeal carcinoma." | 9.19 | Effect of edaravone on radiation-induced brain necrosis in patients with nasopharyngeal carcinoma after radiotherapy: a randomized controlled trial. ( Hu, W; Li, G; Luo, J; Rong, X; Tang, Y; Xu, P; Yang, J; Yang, X, 2014) |
| " This study was designed to evaluate the protective effect of edaravone, a free radical scavenger, on radiation-induced brain necrosis in patients with nasopharyngeal carcinoma." | 5.19 | Effect of edaravone on radiation-induced brain necrosis in patients with nasopharyngeal carcinoma after radiotherapy: a randomized controlled trial. ( Hu, W; Li, G; Luo, J; Rong, X; Tang, Y; Xu, P; Yang, J; Yang, X, 2014) |
| " The mean phenazone half-life time (t0." | 1.27 | Metabolic efficiency of the liver in patients with breast cancer as determined by pharmacokinetics of phenazone. ( Cieślińska, A; Orzechowska-Juzwenko, K; Roszkowska, E; Wiela, A, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (80.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tang, Y | 1 |
| Rong, X | 1 |
| Hu, W | 1 |
| Li, G | 1 |
| Yang, X | 1 |
| Yang, J | 1 |
| Xu, P | 1 |
| Luo, J | 1 |
| TOUSSAINT, R | 1 |
| ZERLETT, G | 1 |
| RITZL, F | 1 |
| Kellermann, G | 1 |
| Luyten-Kellermann, M | 1 |
| Jett, JR | 1 |
| Moses, HL | 1 |
| Fontana, RS | 1 |
| Orzechowska-Juzwenko, K | 1 |
| Wiela, A | 1 |
| Cieślińska, A | 1 |
| Roszkowska, E | 1 |
| Kato, A | 1 |
| Ushio, Y | 1 |
| Hayakawa, T | 1 |
| Yamada, K | 1 |
| Ikeda, H | 1 |
| Mogami, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Edaravone on Radiation-induced Temporal Lobe Necrosis in Patients With Nasopharyngeal Carcinoma After Radiotherapy[NCT01865201] | Phase 2 | 154 participants (Actual) | Interventional | 2009-03-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for antipyrine and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Effect of edaravone on radiation-induced brain necrosis in patients with nasopharyngeal carcinoma after radiotherapy: a randomized controlled trial.
Topics: Adult; Aged; Aged, 80 and over; Antipyrine; Brain Injuries; Carcinoma; Case-Control Studies; Edaravo | 2014 |
4 other studies available for antipyrine and Carcinoma, Anaplastic
| Article | Year |
|---|---|
[On a symptomatic treatment of typical concomitant symptoms in inoperable bronchial carcinoma].
Topics: Antipyrine; Carcinoma; Carcinoma, Bronchogenic; Humans; Osteoarthropathy, Secondary Hypertrophic | 1960 |
Aryl hydrocarbon hydroxylase in man and lung cancer.
Topics: Antipyrine; Carcinoma; Genetic Variation; Humans; Hydrocarbons; Lung Neoplasms; Male; Mixed Function | 1978 |
Metabolic efficiency of the liver in patients with breast cancer as determined by pharmacokinetics of phenazone.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Antipyrine; Biotransformation; Breast N | 1987 |
Circulatory disturbance of the spinal cord with epidural neoplasm in rats.
Topics: Angiography; Animals; Antipyrine; Autoradiography; Carbon Dioxide; Carcinoma; Epidural Space; Female | 1985 |